Saturn V Capital Management LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $265 Billion distributed in 26 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $27.6B, Disc Medicine Inc with a value of $22.7B, Crinetics Pharmaceuticals, Inc. with a value of $21.5B, Vaxcyte, Inc. with a value of $16.3B, and Ascendis Pharma A/S with a value of $15.4B.

Examining the 13F form we can see an increase of $15.2B in the current position value, from $249B to 265B.

Saturn V Capital Management LLC is based out at Austin, TX

Below you can find more details about Saturn V Capital Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $265 Billion
Healthcare: $203 Billion

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 26
  • Current Value $265 Billion
  • Prior Value $249 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 8 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.